Neuroprotective effect of the natural iron chelator, phytic acid in a cell culture model of Parkinson's disease
- 12 March 2008
- journal article
- Published by Elsevier BV in Toxicology
- Vol. 245 (1-2), 101-108
- https://doi.org/10.1016/j.tox.2007.12.017
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Protein Kinase Cδ Negatively Regulates Tyrosine Hydroxylase Activity and Dopamine Synthesis by Enhancing Protein Phosphatase-2A Activity in Dopaminergic NeuronsJournal of Neuroscience, 2007
- 1-Methyl-4-phenylpyridinium-induced alterations of glutathione status in immortalized rat dopaminergic neuronsToxicology and Applied Pharmacology, 2007
- Neuroprotection by iron chelator against proteasome inhibitor-induced nigral degenerationBiochemical and Biophysical Research Communications, 2005
- Mitochondrial membrane depolarization and the selective death of dopaminergic neurons by rotenone: protective effect of coenzyme Q10Journal of Neurochemistry, 2005
- Oxidative stress in Parkinson's diseaseAnnals of Neurology, 2003
- Neuroprotective Strategies in Parkinson's Disease Using the Models of 6‐Hydroxydopamine and MPTPaAnnals of the New York Academy of Sciences, 2000
- IP6: A novel anti-cancer agentLife Sciences, 1997
- Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in miceJournal of Neural Transmission, 1997
- Comparative efficacy and toxicity of desferrioxamine, deferiprone and other iron and aluminium chelating drugsToxicology Letters, 1995
- Biochemical, physiological and medical aspects of ubiquinone functionBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1995